Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mather, K. J.
Right arrow Articles by Baron, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mather, K. J.
Right arrow Articles by Baron, A. D.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 51:3517-3523, 2002
© 2002 by the American Diabetes Association, Inc.

Endothelin Contributes to Basal Vascular Tone and Endothelial Dysfunction in Human Obesity and Type 2 Diabetes

Kieren J. Mather1, Bahram Mirzamohammadi1, Amale Lteif1, Helmut O. Steinberg1, and Alain D. Baron1,2

1 Division of Endocrinology & Metabolism, Indiana University-Purdue University Indianapolis School of Medicine, Indianapolis, Indiana
2 Amylin Pharmaceuticals, Indianapolis, Indiana

Endothelium-dependent vasodilation is impaired in clinical states of insulin resistance such as obesity and type 2 diabetes. Individuals who have hyperinsulinemic insulin resistance have relatively elevated circulating levels of endothelin (ET)-1, suggesting that ET-1 may be important in the endothelial dysfunction and alterations of vascular tone in these conditions. In 8 lean subjects, 12 nondiabetic obese subjects, and 8 subjects with type 2 diabetes, we measured basal and methacholine-stimulated rates of leg blood flow (LBF) and total serum nitrates (NOx) before and after the intrafemoral arterial administration of BQ123, a specific blocker of ETA receptors. BQ123 produced significant vasodilation in the obese and type 2 diabetic subjects (leg vascular resistance = mean arterial pressure/LBF fell by 34 and 36%; P < 0.005) but not in the lean subjects (13%; P = NS, P = 0.018 comparing all groups). ETA blockade did not change basal NOx flux (NOx*LBF). This suggests increased basal ET-1 constrictor tone among obese and type 2 diabetic subjects. BQ123 corrected the baseline defect in endothelium-dependent vasodilation seen in obese and type 2 diabetic subjects, suggesting an important contribution of ET-1 to endothelial dysfunction in these subjects. In contrast to basal conditions, stimulated NOx flux was augmented by BQ123 in obese and type 2 diabetic subjects but not in L subjects (P = 0.04), suggesting a combined effect of ETA blockade to reduce constrictor tone and augment dilator tone. Endothelin seems to contribute to endothelial dysfunction and the regulation of vascular tone in human obesity and type 2 diabetes.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Endocr. Rev.Home page
R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon
Cardiovascular Actions of Insulin
Endocr. Rev., August 1, 2007; 28(5): 463 - 491.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
G. P. Van Guilder, C. M. Westby, J. J. Greiner, B. L. Stauffer, and C. A. DeSouza
Endothelin-1 Vasoconstrictor Tone Increases With Age in Healthy Men But Can Be Reduced by Regular Aerobic Exercise
Hypertension, August 1, 2007; 50(2): 403 - 409.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Fujita, B. B. Rasmussen, J. G. Cadenas, M. J. Drummond, E. L. Glynn, F. R. Sattler, and E. Volpi
Aerobic Exercise Overcomes the Age-Related Insulin Resistance of Muscle Protein Metabolism by Improving Endothelial Function and Akt/Mammalian Target of Rapamycin Signaling
Diabetes, June 1, 2007; 56(6): 1615 - 1622.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Lteif, P. Vaishnava, A. D. Baron, and K. J. Mather
Endothelin Limits Insulin Action in Obese/Insulin-Resistant Humans
Diabetes, March 1, 2007; 56(3): 728 - 734.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. J. Padilla, P. McDonough, B. J. Behnke, Y. Kano, K. S. Hageman, T. I. Musch, and D. C. Poole
Effects of Type II diabetes on capillary hemodynamics in skeletal muscle
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2439 - H2444.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J.-a Kim, M. Montagnani, K. K. Koh, and M. J. Quon
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms
Circulation, April 18, 2006; 113(15): 1888 - 1904.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
T. Radaelli, J. Uvena-Celebrezze, J. Minium, L. Huston-Presley, P. Catalano, and S. Hauguel-de Mouzon
Maternal Interleukin-6: Marker of Fetal Growth and Adiposity
Reproductive Sciences, January 1, 2006; 13(1): 53 - 57.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. Mather and S. Verma
Function determines structure in the vasculature: lessons from insulin resistance
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R305 - R306.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. A. Potenza, F. L. Marasciulo, D. M. Chieppa, G. S. Brigiani, G. Formoso, M. J. Quon, and M. Montagnani
Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H813 - H822.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Gudbjornsdottir, M. Sjostrand, L. Strindberg, and P. Lonnroth
Decreased Muscle Capillary Permeability Surface Area in Type 2 Diabetic Subjects
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1078 - 1082.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Sjostrand, S. Gudbjornsdottir, L. Strindberg, and P. Lonnroth
Delayed Transcapillary Delivery of Insulin to Muscle Interstitial Fluid After Oral Glucose Load in Obese Subjects
Diabetes, January 1, 2005; 54(1): 152 - 157.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
F.-P. Xu, M.-S. Chen, Y.-Z. Wang, Q. Yi, S.-B. Lin, A. F. Chen, and J.-D. Luo
Leptin Induces Hypertrophy via Endothelin-1-Reactive Oxygen Species Pathway in Cultured Neonatal Rat Cardiomyocytes
Circulation, September 7, 2004; 110(10): 1269 - 1275.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Orio Jr., S. Palomba, T. Cascella, B. De Simone, S. Di Biase, T. Russo, D. Labella, F. Zullo, G. Lombardi, and A. Colao
Early Impairment of Endothelial Structure and Function in Young Normal-Weight Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4588 - 4593.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. J. Mather, A. Lteif, H. O. Steinberg, and A. D. Baron
Interactions Between Endothelin and Nitric Oxide in the Regulation of Vascular Tone in Obesity and Diabetes
Diabetes, August 1, 2004; 53(8): 2060 - 2066.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. P. Davy and J. E. Hall
Obesity and hypertension: two epidemics or one?
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2004; 286(5): R803 - R813.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
A. A. da Silva, J. J. Kuo, L. S. Tallam, and J. E. Hall
Role of Endothelin-1 in Blood Pressure Regulation in a Rat Model of Visceral Obesity and Hypertension
Hypertension, February 1, 2004; 43(2): 383 - 387.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
C. Cardillo, U. Campia, M. Iantorno, and J. A. Panza
Enhanced Vascular Activity of Endogenous Endothelin-1 in Obese Hypertensive Patients
Hypertension, January 1, 2004; 43(1): 36 - 40.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.